GO:0031210 phosphatidylcholine binding | Mechanism & Genes

Phosphatidylcholine (PC) is the most abundant phospholipid in eukaryotic membranes, and its binding by proteins is a fundamental molecular function that governs lipid transfer, membrane remodeling, and signal transduction. The Gene Ontology term GO:0031210, phosphatidylcholine binding, captures the ability of a protein or complex to selectively interact with phosphatidylcholine, a glycophospholipid in which a phosphatidyl group is esterified to the hydroxyl group of choline. This function is distinct from enzymatic activities that synthesize or hydrolyze PC; instead, it describes non-covalent recognition of the PC molecule. Researchers study phosphatidylcholine binding to understand how proteins sense and shape membrane lipid composition, how lipids are exchanged between organelles, and how dysregulated lipid binding contributes to disease [5, 6]. Proteins that bind phosphatidylcholine include phosphatidylcholine transfer protein (PC-TP/StARD2), which shuttles PC between membranes and requires PC binding for proper folding and stability. Scavenger receptor class B type 1 (SR-B1) binds PC-containing liposomes, and this interaction is modulated by phosphatidic acid, highlighting the interplay between different lipid species in membrane recognition. Other examples include sigma-1 receptor (SigmaR1), an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis. These examples illustrate that phosphatidylcholine binding is not a passive property but a regulated event with functional consequences for cellular physiology. The importance of phosphatidylcholine binding extends to membrane biophysics, where techniques such as liposome binding assays and kinetic measurements have been used to quantify interactions. For instance, phloretin binding to phosphatidylcholine vesicle membranes has been characterized kinetically, and uranyl binding to phosphatidylcholine liposomes has been shown to affect liposome aggregation and surface area. Bovine factor Va binds phosphatidylcholine membranes, a process relevant to blood coagulation. Together, these studies demonstrate that phosphatidylcholine binding is a measurable and biologically significant molecular function.

GO:0031210 phosphatidylcholine binding is defined by the Gene Ontology as the binding to a phosphatidylcholine, a glycophospholipid in which a phosphatidyl group is esterified to the hydroxyl group of choline. In practical terms, it describes any molecular interaction (non-covalent) between a protein, peptide, or other molecule and a phosphatidylcholine molecule. This function is classified under molecular_function and does not imply catalysis or transport; it is purely a binding event. The term is used to annotate gene products that selectively recognize phosphatidylcholine, often in the context of membrane association, lipid transfer, or lipid sensing.

Phosphatidylcholine binding is important because phosphatidylcholine is the major structural phospholipid in eukaryotic membranes, and proteins that bind it are central to lipid homeostasis, membrane trafficking, and signal transduction. Dysregulation of phosphatidylcholine binding can alter membrane composition, affect lipid droplet formation, and contribute to metabolic and neurodegenerative diseases [3, 5]. Understanding this function provides insight into how cells sense and respond to lipid environments, and it offers targets for therapeutic intervention in conditions such as cancer and lipid disorders.

The following genes and proteins are experimentally linked to phosphatidylcholine binding or its regulation, based on the verified literature.

Phosphatidylcholine binding is regulated at multiple levels. The lipid environment modulates binding: phosphatidic acid alters SR-B1 binding to phosphatidylcholine liposomes. Protein factors such as Sec14 regulate phosphatidylcholine homeostasis, and their activity is influenced by phosphoinositides. Sigma-1 receptor (SigmaR1) is an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis, suggesting that phosphatidylcholine binding may be integrated with ER stress responses. Additionally, the folding and stability of PC-TP depend on phosphatidylcholine binding, indicating that lipid availability can regulate protein function post-translationally.

Altered phosphatidylcholine metabolism and binding are observed in cancer, where changes in membrane lipid composition support proliferation and survival. Proteins that bind phosphatidylcholine, such as SR-B1, are implicated in lipoprotein uptake and may influence tumor growth. Targeting phosphatidylcholine binding proteins could disrupt membrane homeostasis in cancer cells.

Sigma-1 receptor (SigmaR1) is a lipid-binding protein that regulates protein and lipid droplet homeostasis, and its dysfunction is linked to neurodegenerative diseases. Phosphatidylcholine binding may modulate SigmaR1 activity, affecting ER function and neuronal survival. Lipid dyshomeostasis is a common feature of neurodegeneration, making phosphatidylcholine binding a potential therapeutic target.

Factor Va binds phosphatidylcholine membranes, and this interaction is essential for blood coagulation. Defects in factor Va binding can lead to bleeding disorders. Understanding phosphatidylcholine binding in this context informs anticoagulant therapy.

Sec14 regulates phosphatidylcholine homeostasis, and its dysfunction may contribute to lipid disorders. PC-TP (PCTP) mutations affect phosphatidylcholine transfer and folding, potentially leading to metabolic syndrome. These examples highlight the broad impact of phosphatidylcholine binding on human health.

Liposome binding assays using phosphatidylcholine vesicles are standard for measuring phosphatidylcholine binding. For example, phloretin binding to phosphatidylcholine vesicle membranes was characterized kinetically, and uranyl binding to phosphatidylcholine liposomes was measured by changes in aggregation and surface area. These assays can be adapted for high-throughput screening.

Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can quantify binding affinity and kinetics. The binding of factor Va to phosphatidylcholine membranes has been studied using such biophysical methods. These techniques provide dissociation constants and kinetic rates.

CRISPR knockout and knock-in models enable functional dissection of phosphatidylcholine binding proteins. For instance, SCARB1 knockout in HEK293T cells can test its role in liposome binding. SigmaR1 knockout can assess lipid droplet homeostasis. These models link binding to cellular phenotypes.

Fluorescent phosphatidylcholine analogs and lipid probes can visualize binding and transfer in live cells. PC-TP-mediated transfer can be monitored using fluorescent lipids. Imaging approaches reveal spatial and temporal dynamics of phosphatidylcholine binding.

Researchers studying phosphatidylcholine binding-related genes often need to determine whether a candidate gene is causally involved in lipid recognition, membrane homeostasis, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.

Phosphatidylcholine binding (GO:0031210) is a fundamental molecular function that underlies membrane lipid homeostasis, lipid transfer, and cellular signaling. Proteins such as PC-TP, SR-B1, SigmaR1, and factor Va illustrate the diverse biological roles of phosphatidylcholine recognition [1, 3, 4, 6]. Dysregulation of this function is linked to cancer, neurodegeneration, coagulation disorders, and metabolic diseases [1, 3, 4, 5, 7]. CRISPR-based models provide powerful tools to dissect the mechanisms and disease relevance of phosphatidylcholine binding, and EDITGENE offers comprehensive services to support such research.